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Abstract
Background: Venous blood sampling is usually per-
formed using a tourniquet to help locate and define
peripheral veins to achieve successful and safe veni-
puncture. Despite widespread usage of tourniquets
for venipuncture by medical and laboratory staff, very
few are aware of the effects of tourniquet application
on laboratory parameters. In addition, definitive
guidelines regarding when and how to use a tourni-
quet for blood sampling are lacking. The aim of the
present study was to define the optimal sampling
time after tourniquet removal to avoid adverse impact
on laboratory analytes.
Methods: Blood oxygen and carbon dioxide partial
pressure, pH, oxyhemoglobin saturation (satO2),
hematological parameters, serum electrolyte concen-
trations, erythrocyte, deformability and aggregation,
leukocyte activation and nitrite/nitrate concentrations
obtained 180 s after tourniquet release were com-
pared with baseline values for 10 healthy subjects.
Results: Blood gases, hematological parameters and
serum electrolyte levels were not affected by the
application and removal of a tourniquet. However,
there were significant decreases in erythrocyte
deformability at 90, 120, 180 s, and increases in eryth-
rocyte aggregation at 5 and 30 s following removal of
the tourniquet. A significant increase in granulocyte
respiratory burst at 60 s was observed, confirming
leukocyte activation due to application of the tourni-
quet. There were no significant alterations of blood
nitrite/nitrate levels.
Conclusions: Our blood sampling technique which
mimicked the application and release of a tourniquet
indicated unaltered values for routine blood gases,
hematological testing and serum electrolyte levels.
Conversely, hemorheological measurements can be
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affected. Therefore, it is strongly recommended that
tourniquet application should be avoided during
blood sampling or, if this is not possible, the proce-
dure should be well standardized and details of the
sampling method should be reported.
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Introduction
A tourniquet is widely used during blood sampling for
facilitating visualization of the vein and to perform
successful venipuncture. Most of the studies in this
area have investigated changes in hematologic, bio-
chemical, coagulation and rheologic properties of
venous blood at different time points following tour-
niquet application, but these results cannot be easily
adapted to a single standard procedure (1–4). Evi-
dence from previous studies is that tourniquet appli-
cation before blood sampling may affect some
laboratory parameters (1, 4, 5). However, although the
use of a tourniquet for blood sampling has been dis-
cussed in the literature (6–8), there still is lack of
definitive information indicating the most appropriate
timing for blood sampling when a tourniquet is used.
In routine practice, blood samples are usually
obtained without loosening the tourniquet. Thus,
blood withdrawal is very rapid and maintaining the
needle inside the vessel lumen is made easier due to
venous stasis. Alternatively, it has been recommend-
ed that for hemorheological studies, the tourniquet
should be removed at least 5 s prior to the sampling
of blood (9). However, a recent study indicated that
significant alterations may be detected in red blood
cell (RBC) deformability and aggregation 5–90 s after
the removal of tourniquet (10). Surprisingly, RBC
deformability was found to be increased (10), thus
suggesting a role for nitric oxide (NO) in the alteration
of RBC deformability (11).
The aim of the present study was to investigate the
magnitude and duration of changes in blood gases,
hematological parameters, serum electrolyte concen-
trations, hemorheological parameters, nitrite/nitrate
content and granulocyte burst activity in blood sam-
ples obtained shortly after the restoration of venous
flow following a brief occlusion model of tourniquet
application. Blood sampling, including simulated
tourniquet application, was performed with blood
samples obtained consecutively for 3 min after res-
toration of venous blood flow. The primary goal was
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Figure 1 Experimental protocol and blood sampling times.
The study was initiated with blood pressure measurement
followed by blood sampling at defined times after tourniquet
(i.e., pneumatic cuff) removal. NIBP, non-invasive blood
pressure; C, control sample.
to define the optimal sampling time following tour-
niquet removal that did not affect some of the widely




Healthy male subjects (ns10), aged between 25–30 years,
were included in this study. Written informed consent was
obtained and the study was approved by the local Ethics
Committee. The venipuncture procedure for all subjects was
performed by an anesthetist with the subject in a sitting posi-
tion. A 20G catheter (BD Venflon, Pro Safety, Becton Dick-
inson, Helsingborg, Sweden) was inserted into the right
antecubital vein using a tourniquet. The tourniquet was
removed following insertion of the catheter. After insertion
of the catheter and removal of the tourniquet, a 30-min wait-
ing period was observed to allow for stabilization. Following
stabilization, blood pressure in the left arm was measured
and diastolic pressure determined (Figure 1). Control blood
samples were obtained from the catheter as described below
(see Collection of blood samples). A pneumatic cuff was then
applied to the right arm above the previously inserted cath-
eter and venous stasis was imposed for 30 s by inflating the
cuff at a pressure 20 mm Hg higher than diastolic blood pres-
sure (DBP, see next paragraph). The cuff was then deflated
to mimic removal of a tourniquet, and blood samples were
obtained from the catheter at 5, 30, 60, 90, 120, 150, 180 s
following deflation of the cuff. Blood oxygen and carbon
dioxide partial pressures (pO2 and pCO2), pH, oxyhemoglo-
bin saturation (satO2) hematological parameters, serum elec-
trolyte concentrations, RBC deformability and aggregation,
and nitrite/nitrate concentrations were measured in all blood
samples. However, granulocyte respiratory burst was deter-
mined only in the blood samples obtained at baseline (con-
trol) and at 60 and 180 s following cuff deflation.
The use of a cuff pressure 20 mm Hg above DBP was
determined based upon a pilot study performed at the Akde-
niz University Intensive Care Unit using a patient having a
radial artery catheter inserted for blood pressure monitoring.
Eight physicians or nurses, who were unaware of the study
protocol, were asked to apply an elastic tourniquet on the
patients arm with the arterial catheter. The arterial pressure
wave shape observed on a monitor was deformed, but did
not disappear after the tourniquet application. The same
type of deformation was observed when a pneumatic cuff
was applied and gradually inflated to the range of mean arte-
rial pressure for this patient (i.e., systolic blood pressure of
110–120 mm Hg, DBP of 55–60 mm Hg). Therefore, a cuff
pressure ranging between systolic pressure and 20 mm Hg
above DBP was selected for modelling application of the
tourniquet. It should be mentioned that this standardized
procedure resulted in a total occlusion of venous flow during
the inflation of the cuff, but arterial flow was not abolished.
Collection of blood samples
Two separate blood samples were obtained at each time
point:
1. Eight milliliter was collected at control sampling, and at
60 and 120 s following the deflation of the cuff. Four mil-
liliter of blood was obtained at all other time points.
Blood was collected into a syringe containing sodium
heparin (15 IU/mL). These anticoagulated blood samples
were used for analysis of blood pO2, pCO2, pH, satO2,
measurement of RBC deformability and aggregation,
quantification of granulacyte respiratory burst and nitrite/
nitrate concentration. Processing of the specimens was
performed immediately after blood collection except for
quantitation of nitrite/nitrate concentrations. Plasma was
refrigerated (–208C) and used for quantitation of nitrite/
nitrate following collection of specimens from all study
subjects.
2. Four milliliter of blood was obtained using a syringe not
containing anticoagulant, and immediately divided into
two tubes: a) a K2EDTA coated tube (BD Vacutainer Sys-
tems, Preanalytical Solutions, Belliver Industrial Estate,
Plymouth, UK) for analysis of hematological parameters.
b) a serum separator tube containing gel to separate
serum from RBC following centrifugation (Greiner Bio-
One/VACUETTE, Longwood, FL, USA). This was used
for analysis of serum electrolytes. Samples were analys-
ed within 1 h after collection.
Analysis of blood pO2, pCO2, pH, satO2,
hematological parameters and serum electrolyte
concentrations
Analysis of blood pH, partial carbon-dioxide pressure (pCO2),
partial oxygen pressure (pO2), oxygen saturation (satO2),
bicarbonate (HCO3–) content and base excess (BE) was per-
formed by using a Stat Profile CCX blood gas analyzer (Nova
Biomedical, Waltham, MA, USA).
RBC count, white blood cell (WBC) count, hemoglobin,
hematocrit, mean corpuscular volume (MCV), mean corpus-
cular hemoglobin concentration (MCHC), platelets, lympho-
cytes and neutrophils were assayed using a Beckman
Coulter LH 780 (Beckman Coulter Inc, Fullerton, CA, USA).
Serum sodium, potassium, chloride, calcium and magnesi-
um were measured on a Roche/Hitachi Modular System P
(Roche Diagnostics GmbH, Mannheim, Germany).
RBC deformability measurements
RBC deformability was measured as an elongation index (EI)
at 378C for various fluid shear stresses by laser diffraction
analysis using an ektacytometer (LORRCA, RR Mechatronics,
Hoorn, The Netherlands). The principle of the system has
been described elsewhere in detail (12). Briefly, a low hemat-
ocrit suspension of RBC in an isotonic viscous medium (4%
polyvinylpyrrolidone 360 solution; MW 360 kDa) is sheared
in a Couette system composed of a glass cup and a precisely
fitting bob, with a gap of 0.3 mm between the cylinders. A
laser beam is directed through the sample and the diffraction
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pattern produced by the deformed cells is analyzed with a
microcomputer. Based upon the geometry of the elliptical
diffraction pattern, an EI is calculated as: EIs(L–W)/LqW),
where L and W are the length and width of the diffraction
pattern. At a constant shear stress, EI increases with RBC
deformability.
EI values determined at the nine shear stress between
0.3–30 pascal (Pa) were used to calculate the shear stress
required for half-maximal RBC deformation (SS1/2) using
Lineweaver-Burk analysis as described elsewhere (13). Brief-
ly, shear stress – EI curves were linearized by plotting the
reciprocal of EI as the function of the reciprocal of shear
stress. The x-intercept of the line obtained by simple linear
regression corresponds to the negative reciprocal value of
shear stress causing SS1/2. Thus, increased SS1/2 values indi-
cate impairment of RBC deformability.
RBC aggregation measurements
RBC aggregation was assessed using a custom-built photo-
metric aggregometer, interfaced to a digital computer, that
monitored light transmittance through the blood sample
during the aggregation process (14). This device was used
instead of the aggregation mode of the LORCA due to the
smaller sample size (0.1 mL for aggregometer vs. 1 mL blood
required for the LORCA). The shearing portion of the system
consists of two parallel glass plates with a gap of 0.3 mm
between them. A stepper motor, controlled by the computer,
rotates one of these plates. The blood sample under inves-
tigation is placed between the glass plates, and is first
sheared at 500 s–1 for 10 s to disperse pre-existing RBC
aggregates. Following a sudden stop of the motor, the infra-
red light transmission through the blood sample is moni-
tored for 10 s, integrated by the computer, and a
dimensionless index calculated that increases with the
extent of RBC aggregation. Measurements were performed
in triplicate for each sample, and the mean of the three
measurements used as the result. RBC aggregation was
measured for cells in autologous plasma and for cells re-
suspended in isotonic phosphate buffer saline (PBS)
(290 mOsm/kg, pHs7.4) containing 0.5% dextran 500
(500 kDa, Sigma Chemical Co, St Louis, CA, USA) to deter-
mine the intrinsic tendency of RBCs to aggregate (15). Meas-
urements were carried out at 378C with the hematocrit of all
samples adjusted to 0.4 L/L.
Quantification of granulocyte respiratory burst
The principle of the method has been described elsewhere
(16). Briefly, granulocytes were isolated from whole blood
using polysucrose density gradients (Histopaque 1119;
Sigma Chemical Co.) as described previously (17). Isolated
granulocytes were washed with and suspended in PBS at a
cell count of 2.5=106/mL. The granulocyte suspension was
then incubated in the dark at 378C for 25 min in the presence
of 10–6 mol/L 29, 79-dichlorofluorescrein diacetate (Catalogue
No: D-6883; Sigma Chemical Co.). The fluorescence of
dichlorofluorescrein diacetate was determined in granulo-
cyte suspensions (106/mL PBS) using a Perkin Elmer LS-50
spectrofluorometer (Spectral Genomics, Boston, MA, USA)
with 335 nm excitation and 655 nm emission wavelengths,
the intensity of the fluorescence being directly related to the
degree of activation of granulocytes, and therefore, granu-
locyte respiratory burst. Preparation of each specimen for
quantitation of granulocyte respiratory burst took 1 h. Since
every specimen was prepared in the same manner, the
results were assumed to reflect the activation status of gran-
ulocytes at the time of specimen collection.
Quantification of nitrite/nitrate concentration
Nitrite/nitrate concentration in RBC suspensions was quan-
tified using a colorimetric kit (No: 78001, nitrite/nitrate calor-
imetric assay kit; Cayman Chemical, Ann Arbor, MI, USA);
the principle of the method has been previously described
(18). Blood samples were centrifuged at 800 g for 6 min to
isolate plasma. Proteins were removed from plasma sam-
ples by centrifugation at 100,000 g for 30 min at 48C. Follow-
ing centrifugation, the plasma was transferred to a 10-kDa
cut-off filter (Millipore Corporation, Billerica, MA, USA) and
re-centrifuged at 18,000 g for 120 min at 48C. The resultant
fluid was incubated with nitrate reductase and its cofactor at
room temperature (20–228C) for 3 h. After a second incuba-
tion with Griess reactants (R1, R2) for 10 min, absorbance
was measured with a Thermo Labsystems multiscan, spec-
trum-1500 spectrophotometer (Thermo Fisher Scientific,
Waltham, MA, USA) at 540 nm. Nitrite/nitrate concentrations
were calculated using a standard curve.
Statistical analysis
Values are presented as mean"SE of the mean. One-way
analysis of variance (ANOVA) was used for repeated meas-
ures followed by Dunnetts Multiple Comparison post-hoc
test. The level of statistical significance was set at p-0.05.
Analysis was performed using Graphpad Prism IV software
(GraphPad Software Inc, La Jolla, CA, USA).
Results
Blood pO2, pCO2, pH, satO2, hematological
parameters and serum electrolyte concentrations
Blood pO2, pCO2, satO2 and HCO3– values were not
different in the samples obtained at 30 s intervals dur-
ing the 3 min period following the restoration of
venous flow. However, blood pH values were found
to be decreased at 5 and 30 s following deflation of
the pneumatic cuff. Values returned to baseline after-
wards (Table 1).
Hematological parameters including RBC, WBC,
platelet, lymphocyte and neutrophil counts, hemoglo-
bin, hematocrit, MCV and MCHC were not signifi-
cantly altered in any of the samples following cuff
deflation (Table 2). Serum sodium, potassium, calci-
um and magnesium levels were also unaffected
(Table 3).
RBC deformability
SS1/2 values were found to be significantly increased
at 90, 120 and 180 s after the pneumatic cuff was
deflated but were not affected at earlier time points
(Table 4). This indicated impaired RBC deformability.
RBC aggregation
RBC aggregation measured in autologous plasma
was found to be increased significantly at 5 (p-0.05)
and 30 s (p-0.01) after release of the pneumatic cuff.
Values returned to baseline after 120 s (Table 4).
RBC aggregation measured in isotonic PBS contain-
ing 0.5% dextran 500 was not altered in any of the
blood samples obtained after removal of the pneu-
matic cuff (p)0.05) (Table 4).
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Figure 2 Granulocyte activation (i.e., respiratory burst) prior
to and after release of pressure cuff.
Fluorescence intensity was increased at 120 s and returned
to control at 240 s. Data are mean"SE, ns10. Difference
from control; *p-0.05.
Granulocyte respiratory burst
Granulocyte respiratory burst increased at 60 s
(p-0.01) and returned to baseline values at 180 s
(p)0.05) following deflation of the cuff (Figure 2).
Nitrite/nitrate concentration
Plasma nitrite/nitrate concentrations did not change at
any sampling time after deflation of the pneumatic
cuff (p)0.05) (Table 3).
Discussion
The results of the present study indicate that blood
gases, hematological parameters and serum electro-
lyte concentrations were not significantly affected by
temporary venous stasis when using a pneumatic cuff
as a model for tourniquet use during blood sampling.
These findings are in contrast with previous reports
(1, 2). However, there were significant decreases in
RBC deformability and increases in RBC aggregation
following release of the pneumatic cuff. Granulocyte
respiratory burst was significantly increased at 60 s
after the restoration of venous flow, indicating acti-
vation following a short 30 s period of venous stasis.
Finally, restoration of venous flow following 30 s of
stasis did not cause significant alterations in blood
nitrite/nitrate concentrations.
A decrease in pO2 during tourniquet application
that occludes venous return for 10 min has been pre-
viously reported (4). However, this 10 min duration is
20-fold longer than the 30 s used in this study. It
should be noted that blood flow was restored before
the start of sampling for both the current and previous
study (4). The previous study reported a return of
blood gas levels to baseline concentrations 60 s post-
occlusion. This finding is consistent with our results
at 60 s (Table 1). Blood pH was found to be slightly
decreased at 5 and 30 s after cuff deflation (Table 1).
No significant changes in serum concentrations of
sodium, potassium, chloride, calcium and magnesi-
um were observed after release of the cuff. Renoe et
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al. observed increased serum calcium concentrations
at 1 min following the application of a pneumatic cuff
(19). However, the duration of stasis was 3 min com-
pared to 30 s used in this study. Furthermore, the
effect of stasis was enhanced if the arm used for sam-
pling was exercised. Continuous occlusion of venous
flow following tourniquet use can alter electrolyte
concentrations. Lippi et al. (2) report a significant
decrease in potassium and a significant increase in
calcium after 1 min of occlusion, a decrease of chlo-
ride at 3 min and unchanged sodium at both 1 and
3 min. However, Lippi et al. (2) obtained samples dur-
ing venous stasis and not following restoration of
blood flow.
Hematological parameters were not influenced by
the 30 s period of venous stasis, regardless of the
sampling following restoration of blood flow. The dis-
crepancy between the results of the current study and
the data from the previous studies exploring the
effects of tourniquet application on clinical chemistry
and hematological parameters may result from differ-
ences in the duration of venous stasis (tourniquet
application) between studies (1, 2). Previous studies
were performed with venous stasis following the
application of a standardized external pressure of
60 mm Hg for 1 and 3 min. The external pressure was
maintained until venipuncture and collection of blood
were completed. However, in the current study,
venous stasis was imposed for 30 s by inflating the
cuff at a pressure 20 mm Hg higher than DBP, and
blood samples were collected following deflation of
the cuff.
Hemorheological changes after venous stasis, with
or without arterial occlusion, have been reported pre-
viously (4, 5), with impairment of RBC deformability
generally consistent with our findings. In the study by
Forconi (4), whole blood filtration returned to baseline
values in samples that were withdrawn 1 min after the
release of cuff pressure. Subsequent measurements
were not performed. However, in the current study,
changes in RBC deformability started 90 s after res-
toration of venous flow, and did not return to baseline
values at 3 min. In contrast, a recent study showed
that RBC deformability was improved, rather than
impaired, following removal of the tourniquet, with
the alterations that were observed at 60 s no longer
evident at 90 s (10). The discrepancy between the
present study and the recent report (10) is most likely
due to different approaches to stop blood flow. The
pressure applied in the current study was well-
defined (i.e., 20 mm Hg above diastolic), and thus was
sufficient to occlude venous blood flow but not stop
arterial inflow. Based upon the results of pilot studies
to determine the appropriate pressure (see Study
design above), we believe that our approach repre-
sents a more realistic model of tourniquet use during
blood collection.
RBC aggregation in blood samples obtained at 5
and 30 s after restoration of venous flow was found
to be increased in autologous plasma, but not in the
standard 0.5% dextran 500 aggregating medium
(Table 4). These findings indicate that cellular factors
contributing to RBC aggregation were not altered due
to venous stasis. Rather, alterations in plasma com-
position (e.g., increased concentration of fibrinogen
resulting from local fluid shifts) may be responsible
for enhanced aggregation in plasma. Our findings of
no changes between 60 and 180 s are in contrast to
those of a previous report (10) which showed a
decrease in RBC aggregation 90 s after the restoration
of blood flow. As in previous studies different
approaches used to stop blood flow may be respon-
sible for these differences.
The mechanisms causing alterations in the para-
meters we studied following tourniquet application
are not well known. Thus, we considered two factors
that may be responsible for these changes.
(1) Neutrophil activation. Venous stasis may affect
the number of marginated leukocytes and the number
of blood cells adhering to venous endothelium.
Leukocyte activation may increase with decreased
venous blood flow velocity and shear rate (20). Also
blood stasis and venous hypertension may lead to
release of inflammatory mediators and growth factors
that trigger the process of leukocyte recruitment and
activation, migration, rolling and infiltration of the
vessel wall (21). The results of the current study
revealed an increase in granulocyte respiratory burst
at 60 s which returned to baseline values at 180 s. It
has been previously reported that activated leuko-
cytes induce structural and functional alterations in
neighboring RBC, including increased membrane
lipid peroxidation and cell lysis, changes in RBC
membrane skeletal proteins (e.g., cross-linking
between spectrin and hemoglobin), and decreased
RBC deformability (22–24). RBC aggregation has also
been found to be enhanced by activated neutrophils,
with the increase mediated by both proteolytic
enzymes and oxygen free radicals (24). Thus the alter-
ations of RBC deformability and aggregation in the
current study may have resulted from leukocyte acti-
vation induced by venous stasis.
(2) Nitric oxide generation. NO is a well-known
vasoactive mediator which regulates vascular tone,
platelet aggregation, coagulation, fibrinolysis and leu-
kocyte activation (25). Release of NO from vascular
endothelium may be influenced by wall shear stress,
intravascular stasis and ischemia-reperfusion injury
(26, 27). In a previous study, plasma nitrate concen-
tration was found to be significantly higher 5 min after
reperfusion, compared to concentrations prior to
ischemia (28). NO has also been shown to play a sig-
nificant role in the regulation of RBC mechanical prop-
erties (11, 29), with a biphasic effect dependent on NO
concentration (11). In addition to NO from external
sources, NO generated within RBC has been suggest-
ed to influence deformability, based on observations
related to significant effects of nitric oxide synthase
(NOS) inhibitors (11). Recent studies have document-
ed the activity of NOS in RBC. This NOS has proper-
ties similar to endothelial NOS (29, 30).
It has been suggested that NO may play a protec-
tive role in various patho-physiological processes
characterized by impaired microcirculatory perfusion
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(e.g., ischemia-reperfusion injury, sepsis, sickle-cell
disease) (30). Therefore, it is tempting to suggest that
alterations of NO generation may have played a role
in hemorheological alterations following restoration
of blood flow. However, in the current study, no sig-
nificant change in the concentration of plasma nitrite/
nitrate was observed, thereby excluding this possibil-
ity. Nevertheless, this finding should be interpreted
cautiously as methods more sensitive than the Griess
assay, which measures nitrite/nitrate concentration in
the nM range, could indicate changes in NO activity
(31).
In this study, blood samples were obtained from a
catheter to collect serial blood samples and avoid
multiple attempts at venipuncture after the release of
the tourniquet. However, use of catheters to collect
routine samples is not the normal procedure and this
may influence several laboratory parameters. Extra-
polating our findings to the design of routine blood
collection procedures using needles should be one
with caution. Another limitation of the current study
was the lack of a parameter to evaluate platelet func-
tion. Platelet function might be changed after tourni-
quet release since shear stress is an important
activator of platelets.
In conclusion, the results of this study indicate that
blood sampling for the measurement of blood gases,
hematological parameters or serum electrolyte con-
centrations can be performed with the application of
a tourniquet for 30 s without any adverse effects on
these measured parameters. However, hemorheolo-
gical changes do occur following application of a tour-
niquet. Therefore, it is strongly recommended that
tourniquet application should be avoided during
blood collection for the investigation of hemorheolo-
gical parameters. If this is not possible, the procedure
should be standardized and details of the sampling
method should be reported.
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